| Scott D Lifchez, MD | |
|
4940 Eastern Ave, Baltimore, MD 21224-2735 | |
| (410) 550-0100 | |
| Not Available |
| Full Name | Scott D Lifchez |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 25 Years |
| Location | 4940 Eastern Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962443267 | NPI | - | NPPES |
| 410639300 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | D62331 (Maryland) | Secondary |
| 2082S0105X | Plastic Surgery - Surgery Of The Hand | D62331 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
In a paper to be published in the forthcoming issue in NANO, researchers from Zhejiang have uncovered a novel method of using nanocarrier-based biological fluorescent probes for detecting amphetamine and ketamine in latent fingermark, in a bid to combat drug abuse.
Queensland health are in a spot of bother yet again over the employment of a foreign born doctor.
Patients with bowel cancer that has spread to the liver and who are eligible for surgery, are around 40 per cent more likely to survive if they undergo an operation to remove the liver disease.
An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.
› Verified 4 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
In a paper to be published in the forthcoming issue in NANO, researchers from Zhejiang have uncovered a novel method of using nanocarrier-based biological fluorescent probes for detecting amphetamine and ketamine in latent fingermark, in a bid to combat drug abuse.
Queensland health are in a spot of bother yet again over the employment of a foreign born doctor.
Patients with bowel cancer that has spread to the liver and who are eligible for surgery, are around 40 per cent more likely to survive if they undergo an operation to remove the liver disease.
An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott D Lifchez, MD 6201 Greenleigh Ave, Middle River, MD 21220-2004 Ph: (410) 933-6423 | Scott D Lifchez, MD 4940 Eastern Ave, Baltimore, MD 21224-2735 Ph: (410) 550-0100 |
News Archive
In a paper to be published in the forthcoming issue in NANO, researchers from Zhejiang have uncovered a novel method of using nanocarrier-based biological fluorescent probes for detecting amphetamine and ketamine in latent fingermark, in a bid to combat drug abuse.
Queensland health are in a spot of bother yet again over the employment of a foreign born doctor.
Patients with bowel cancer that has spread to the liver and who are eligible for surgery, are around 40 per cent more likely to survive if they undergo an operation to remove the liver disease.
An internationally renowned gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.
› Verified 4 days ago
Derek Lee Masden, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, Baltimore, MD 21218 Phone: 585-233-9659 | |
Dr. Bao-quynh Thuy Julian, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St # 8161, Baltimore, MD 21287 Phone: 443-997-9466 Fax: 410-614-4333 | |
Jonathan Eitan Miller, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-9441 | |
Dr. Joseph C Orlando, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5601 Loch Raven Blvd, Suite 101, Pob, Baltimore, MD 21239 Phone: 410-433-4300 Fax: 410-433-4491 | |
Kerry Elizabeth Owens, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Frederick Rd, Suite 200, Baltimore, MD 21228 Phone: 410-744-0900 Fax: 410-744-3160 | |
Dr. James P. Higgins, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St, 2nd Fl, Baltimore, MD 21218 Phone: 410-235-5405 | |
Maakan Taghizadeh, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 300 Frederick Rd, Suite 200, Baltimore, MD 21228 Phone: 410-744-0900 Fax: 410-744-3160 |